Current role of melatonin in pediatric neurology: Clinical recommendations

European Journal of Paediatric Neurology

Volumn 19, Issue 2, 2015, Pages 122-133

  Bruni, Oliviero ^a   Alonso Alconada, Daniel ^b,c   Besag, Frank ^d   Biran, Valerie ^e,f   Braam, Wiebe ^g,h   Cortese, Samuele ^i,j,k   Moavero, Romina ^l,m   Parisi, Pasquale ⁿ   Smits, Marcel ^h,o   Van Der Heijden, Kristiaan ^p   Curatolo, Paolo ^l  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d Bedfordshire and Institute of Psychiatry ^*  (United Kingdom)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g Department Advisium   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^j UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^k NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^l UNIVERSITY OF ROME TOR VERGATA   (Italy)

^m BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

ⁿ SAPIENZA UNIVERSITY OF ROME   (Italy)

^o GELDERSE VALLEI HOSPITAL   (Netherlands)

^p LEIDEN UNIVERSITY   (Netherlands)

more..

Author keywords

ADHD; Autism; Epilepsy; Insomnia; Melatonin treatment; Sleep disorders

Indexed keywords

MELATONIN;

AROUSAL; ATTENTION DEFICIT DISORDER; AUTISM; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CONSENSUS; DELAYED SLEEP PHASE SYNDROME; DEVELOPMENTAL DISORDER; DIAGNOSTIC PROCEDURE; DIARRHEA; DIZZINESS; DROWSINESS; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG MECHANISM; DRUG SAFETY; ELECTROENCEPHALOGRAM; ENURESIS; EPILEPSY; EVOKED BRAIN STEM AUDITORY RESPONSE; HEADACHE; HORMONE ACTION; HUMAN; HYPOTHERMIA; INSOMNIA; INTELLECTUAL IMPAIRMENT; LIGHT; META ANALYSIS (TOPIC); NERVE CELL LESION; NEUROPROTECTION; PERINATAL ASPHYXIA; PRACTICE GUIDELINE; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDER; SLEEP TIME; ANIMAL; CHILD; DRUG EFFECTS; FEMALE; MALE; NEUROLOGY; PEDIATRICS; PROCEDURES; SLEEP;

ANIMALS; CHILD; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; NEUROLOGY; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; SLEEP;

EID: 84923069433     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2014.12.007     Document Type: Review

References (121)

1. N. Gordon The therapeutics of melatonin: a paediatric perspective Brain Dev 22 2000 213 217
2. D.J. Kennaway Melatonin and development: physiology and pharmacology Semin Perinatol 24 2000 258 266
3. J.L. Mauriz, P.S. Collado, C. Veneroso, R.J. Reiter, and J. Gonzalez-Gallego A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives J Pineal Res 54 2013 1 14
4. L.P. Niles, K.J. Armstrong, and L.M. Rincon Castro Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers BMC Neurosci 5 2004 41
5. S. Iwasaki, K. Nakazawa, and J. Sakai Melatonin as a local regulator of human placental function J Pineal Res 39 2005 261 265
6. S. Comai, R. Ochoa-Sanchez, and G. Gobbi Sleep-wake characterization of double MT(1)/MT(2) receptor knockout mice and comparison with MT(1) and MT(2) receptor knockout mice Behav Brain Res 243 2013 231 238
7. A. Wirz-Justice, and S.M. Armstrong Melatonin: nature's soporific? J Sleep Res 5 1996 137 141
8. J.E. Nagtegaal, G.A. Kerkhof, M.G. Smits, A.C. Swart, and Y.G. Van Der Meer Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset J Sleep Res 7 1998 135 143
9. I.M. van Geijlswijk, H.P. Korzilius, and M.G. Smits The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis Sleep 33 2010 1605 1614
10. I.M. van Geijlswijk, K.B. van der Heijden, A.C. Egberts, H.P. Korzilius, and M.G. Smits Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT Psychopharmacology 212 2010 379 391
11. W. Braam, I. van Geijlswijk, and H. Keijzer Loss of response to melatonin treatment is associated with slow melatonin metabolism J Intellect Disabil Res 54 2010 547 555
12. R.E. Appleton, and P. Gringras Melatonin: helping to MEND impaired sleep Arch Dis Child 98 2013 216 217
13. J.A. Owens, C.L. Rosen, and J.A. Mindell Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians Pediatrics 111 2003 e628 e635
14. J.A. Owens Pharmacotherapy of pediatric insomnia J Am Acad Child Adolesc Psychiatry 48 2009 99 107
15. J.A. Owens, C.L. Rosen, J.A. Mindell, and H.L. Kirchner Use of pharmacotherapy for insomnia in child psychiatry practice: a national survey Sleep Med 11 2010 692 700
16. I. Hartz, K. Furu, T. Bratlid, M. Handal, and S. Skurtveit Hypnotic drug use among 0-17 year olds during 2004-2011: a nationwide prescription database study Scand J public health 40 2012 704 711
17. H. Heussler, P. Chan, and A.M. Price Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian paediatric research network survey Sleep Med 14 2013 189 194
18. N.M. Merchant, D.V. Azzopardi, and A.F. Hawwa Pharmacokinetics of melatonin in preterm infants Br J Clin Pharmacol 76 2013 725 733
19. A. Sadeh Sleep and melatonin in infants: a preliminary study Sleep 20 1997 185 191
20. M.K. LeBourgeois, M.A. Carskadon, and L.D. Akacem Circadian phase and its relationship to nighttime sleep in toddlers J Biol Rhythms 28 2013 322 331
21. H. Shinohara, and H. Kodama Relationship between circadian salivary melatonin levels and sleep-wake behavior in infants Pediatr Int off J Jpn Pediatr Soc 53 2011 29 35
22. R. Tauman, N. Zisapel, M. Laudon, H. Nehama, and Y. Sivan Melatonin production in infants Pediatr Neurol 26 2002 379 382
23. L. Hartmann, M. Roger, B.J. Lemaitre, J.F. Massias, and J.L. Chaussain Plasma and urinary melatonin in male infants during the first 12 months of life Clin Chimica Acta Int J Clin Chem 121 1982 37 42
24. A. Attanasio, K. Rager, and D. Gupta Ontogeny of circadian rhythmicity for melatonin, serotonin, and N-acetylserotonin in humans J Pineal Res 3 1986 251 256
25. F. Waldhauser, G. Weiszenbacher, and H. Frisch Fall in nocturnal serum melatonin during prepuberty and pubescence Lancet 1 1984 362 365
26. B. Griefahn, P. Brode, M. Blaszkewicz, and T. Remer Melatonin production during childhood and adolescence: a longitudinal study on the excretion of urinary 6-hydroxymelatonin sulfate J Pineal Res 34 2003 26 31
27. M.G. Smits, H.F. van Stel, and K. van der Heijden Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial J Am Acad Child Adolesc Psychiatry 42 2003 1286 1293
28. A. van Maanen, A.M. Meijer, M.G. Smits, and F.J. Oort Termination of short term melatonin treatment in children with delayed dim light melatonin onset: effects on sleep, health, behavior problems, and parenting stress Sleep Med 12 2011 875 879
29. M. Hoebert, K.B. van der Heijden, I.M. van Geijlswijk, and M.G. Smits Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia J Pineal Res 47 2009 1 7
30. I.M. van Geijlswijk, R.H. Mol, T.C. Egberts, and M.G. Smits Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia Psychopharmacology 216 2011 111 120
31. H.J. Burgess, V.L. Revell, T.A. Molina, and C.I. Eastman Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg J Clin Endocrinol Metab 95 2010 3325 3331
32. EFSA Panel on dietetic products NaAN. Scientific opinion on the substantiation of health claims related to melatonin and alleviation of subjective feelings of jet lag (ID 1953), and reduction of sleep onset latency, and improvement of sleep quality (ID 1953) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA J 8 2010 1467
33. EFSA Panel on dietetic products NaAN. Scientific Opinion on the substantiation of a health claim related to melatonin and reduction of sleep onset latency (ID 1698, 1780, 4080) pursuant to article 13(1) of regulation (EC) no 1924/2006 EFSA J 9 2011 2241
34. K.B. van der Heijden, M.G. Smits, E.J. van Someren, and W. Boudewijn Gunning Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia J Sleep Res 14 2005 187 194
35. H. Keijzer, M.G. Smits, and T. Peeters Evaluation of salivary melatonin measurements for dim light melatonin onset calculations in patients with possible sleep-wake rhythm disorders Clin Chimica Acta Int J Clin Chem 412 2011 1616 1620
36. H. Keijzer, M.G. Smits, J.F. Duffy, and L.M. Curfs Why the dim light melatonin onset (DLMO) should be measured before treatment of patients with circadian rhythm sleep disorders Sleep Med Rev 18 2014 333 339
37. K. Shibui, M. Uchiyama, and M. Okawa Melatonin rhythms in delayed sleep phase syndrome J Biol Rhythms 14 1999 72 76
38. T. Ebisawa, M. Uchiyama, and N. Kajimura Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome EMBO Rep 2 2001 342 346
39. S.N. Archer, D.L. Robilliard, and D.J. Skene A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference Sleep 26 2003 413 415
40. M. Gradisar, and S.J. Crowley Delayed sleep phase disorder in youth Curr Opin Psychiatry 26 2013 580 585
41. G. Micic, A. de Bruyn, and N. Lovato The endogenous circadian temperature period length (tau) in delayed sleep phase disorder compared to good sleepers J Sleep Res 22 2013 617 624
42. N. Buscemi, B. Vandermeer, and N. Hooton The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis J Gen Intern Med 20 2005 1151 1158
43. E. Ferracioli-Oda, A. Qawasmi, and M.H. Bloch Meta-analysis: melatonin for the treatment of primary sleep disorders PLoS One 8 2013 e63773
44. M.G. Smits, E.E. Nagtegaal, J. van der Heijden, A.M. Coenen, and G.A. Kerkhof Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial J Child Neurol 16 2001 86 92
45. B. Eckerberg, A. Lowden, R. Nagai, and T. Akerstedt Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study Chronobiol Int 29 2012 1239 1248
46. A. Wilhelmsen-Langeland, I.W. Saxvig, and S. Pallesen A randomized controlled trial with bright light and melatonin for the treatment of delayed sleep phase disorder: effects on subjective and objective sleepiness and cognitive function J Biological Rhythms 28 2013 306 321
47. I.W. Saxvig, A. Wilhelmsen-Langeland, and S. Pallesen A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: effects on subjective and objective sleep Chronobiol Int 31 2014 72 86
48. W. Braam, M.G. Smits, and R. Didden Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis Dev Med Child Neurol 51 2009 340 349
49. N. Buscemi, B. Vandermeer, and N. Hooton Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis BMJ 332 2006 385 393
50. S. Cortese, S.V. Faraone, E. Konofal, and M. Lecendreux Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies J Am Acad Child Adolesc Psychiatry 48 2009 894 908
51. S. Cortese, M. Lecendreux, M.C. Mouren, and E. Konofal ADHD and insomnia J Am Acad Child Adolesc Psychiatry 45 2006 384 385
52. R. Kirov, and S. Brand Sleep problems and their effect in ADHD Expert Rev Neurother 14 2014 287 299
53. S. Cortese, T.E. Brown, and P. Corkum Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 52 2013 784 796
54. K.B. Van der Heijden, M.G. Smits, E.J. Van Someren, and W.B. Gunning Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder Chronobiol Int 22 2005 559 570
55. P. Chaste, N. Clement, and H.G. Botros Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders J Pineal Res 51 2011 394 399
56. Interventions CHfSRo. Cochrane Handbook for systematic reviews of interventions, Version 5.1.0 [updated March 2011]. In: Higgins JPT GS editor.
57. J. Owens, R. Gruber, and T. Brown Future research directions in sleep and ADHD: report of a consensus working group J Atten Disord 17 2013 550 564
58. C.V. Tjon Pian Gi, J.P. Broeren, J.S. Starreveld, and F.G. Versteegh Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study Eur J Pediatr 162 2003 554 555
59. M.D. Weiss, M.B. Wasdell, M.M. Bomben, K.J. Rea, and R.D. Freeman Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia J Am Acad Child Adolesc Psychiatry 45 2006 512 519
60. K.B. Van der Heijden, M.G. Smits, E.J. Van Someren, K.R. Ridderinkhof, and W.B. Gunning Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia J Am Acad Child Adolesc Psychiatry 46 2007 233 241
61. M.R. Mohammadi, S.A. Mostafavi, and S.A. Keshavarz Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial Iran J psychiatry 7 2012 87 92
62. P. Krakowiak, B. Goodlin-Jones, I. Hertz-Picciotto, L.A. Croen, and R.L. Hansen Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study J Sleep Res 17 2008 197 206
63. B. Sivertsen, M.B. Posserud, C. Gillberg, A.J. Lundervold, and M. Hysing Sleep problems in children with autism spectrum problems: a longitudinal population-based study Autism Int J Res Pract 16 2012 139 150
64. S. Tordjman, G.M. Anderson, N. Pichard, H. Charbuy, and Y. Touitou Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder Biol Psychiatry 57 2005 134 138
65. S.E. Goldman, K.W. Adkins, and M.W. Calcutt Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep J Autism Dev Disord 44 2014 2525 2535
66. O.J. Veatch, J.S. Pendergast, and M.J. Allen Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay J Autism Dev Disord 2014 ePub ahead of print
67. D.A. Rossignol, and R.E. Frye Melatonin in autism spectrum disorders: a systematic review and meta-analysis Dev Med Child Neurol 53 2011 783 792
68. W. Braam, H. Keijzer, and H. Struijker Boudier CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder? J Intellect Disabil Res 57 2013 993 1000
69. S. Tordjman, I. Najjar, and E. Bellissant Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives Int J Mol Sci 14 2013 2050 8 205042
70. R.A. Harrington, L.C. Lee, R.M. Crum, A.W. Zimmerman, and I. Hertz-Picciotto Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy Autism Res off J Int Soc Autism Res 6 2013 149 168
71. E. Daly, C. Ecker, and B. Hallahan Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion Brain 137 2014 2600 2610
72. S.G. Sajith, and D. Clarke Melatonin and sleep disorders associated with intellectual disability: a clinical review J Intellect Disabil Res 51 2007 2 13
73. P. Gringras, C. Gamble, and A.P. Jones Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial BMJ 345 2012 e6664
74. S. Hartter, C. Ursing, and S. Morita Orally given melatonin may serve as a probe drug for cytochrome P450 1A2 activity in vivo: a pilot study Clin Pharmacol Ther 70 2001 10 16
75. H. De Leersnyder Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment Trends Endocrinol Metab TEM 17 2006 291 298
76. C.L. Chik, M.D. Rollag, W.C. Duncan, and A.C. Smith Diagnostic utility of daytime salivary melatonin levels in Smith-Magenis syndrome Am J Med Genet A 152A 2010 96 101
77. W. Braam, R. Didden, M.G. Smits, and L.M. Curfs Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial J Child Neurol 23 2008 649 654
78. O. Bruni, F. Cortesi, F. Giannotti, and P. Curatolo Sleep disorders in tuberous sclerosis: a polysomnographic study Brain Dev 17 1995 52 56
79. F.J. O'Callaghan, A.A. Clarke, E. Hancock, A. Hunt, and J.P. Osborne Use of melatonin to treat sleep disorders in tuberous sclerosis Dev Med Child Neurol 41 1999 123 126
80. E. Hancock, F. O'Callaghan, and J.P. Osborne Effect of melatonin dosage on sleep disorder in tuberous sclerosis complex J Child Neurol 20 2005 78 80
81. A.J. McArthur, and S.S. Budden Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment Dev Med Child Neurol 40 1998 186 192
82. H. De Leersnyder, N. Zisapel, and M. Laudon Prolonged-release melatonin for children with neurodevelopmental disorders Pediatr Neurol 45 2011 23 26
83. J. Fraser, J.E. Wraith, and M.B. Delatycki Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians Clin Genet 62 2002 418 421
84. J. Fraser, A.A. Gason, J.E. Wraith, and M.B. Delatycki Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study Arch Dis Child 90 2005 1239 1242
85. S. Woolfenden, V. Sarkozy, G. Ridley, M. Coory, and K. Williams A systematic review of two outcomes in autism spectrum disorder - epilepsy and mortality Dev Med Child Neurol 54 2012 306 312
86. H. Goldberg-Stern, H. Oren, N. Peled, and B.Z. Garty Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study J Child Neurol 27 2012 1524 1528
87. F. Brigo, and A. Del Felice Melatonin as add-on treatment for epilepsy Cochrane Database Syst Rev 6 2012 CD006967
88. S. Jain, and F.M. Besag Does melatonin affect epileptic seizures? Drug safety Int J Med Toxicol drug Exp 36 2013 207 215
89. V. Srinivasan, S.R. Pandi-Perumal, and D.W. Spence Potential use of melatonergic drugs in analgesia: mechanisms of action Brain Res Bull 81 2010 362 371
90. R.J. Reiter, D.X. Tan, and A. Galano Melatonin: exceeding expectations Physiology 29 2014 325 333
91. M. Wilhelmsen, I. Amirian, R.J. Reiter, J. Rosenberg, and I. Gogenur Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies J Pineal Res 51 2011 270 277
92. J.E. Nagtegaal, M.G. Smits, A.C. Swart, G.A. Kerkhof, and Y.G. van der Meer Melatonin-responsive headache in delayed sleep phase syndrome: preliminary observations Headache 38 1998 303 307
93. O. Bruni, F. Galli, and V. Guidetti Sleep hygiene and migraine in children and adolescents. Cephalalgia Int J headache 19 Suppl. 25 1999 57 59
94. J. Rovers, M. Smits, and J.F. Duffy Headache and sleep: also assess circadian rhythm sleep disorders Headache 54 2014 175 177
95. V. Guidetti, C. Dosi, and O. Bruni The relationship between sleep and headache in children: implications for treatment Cephalalgia Int J headache 34 2014 767 776
96. S. Miano, P. Parisi, and A. Pelliccia Melatonin to prevent migraine or tension-type headache in children Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 29 2008 285 287
97. R. Fallah, F.F. Shoroki, and F. Ferdosian Safety and efficacy of melatonin in pediatric migraine prophylaxis Curr drug Saf 2014 ePub ahead of print
98. A.C. Lee, N. Kozuki, and H. Blencowe Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990 Pediatr Res 74 Suppl. 1 2013 50 72
99. D. Alonso-Alconada, A. Alvarez, O. Arteaga, A. Martinez-Ibarguen, and E. Hilario Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia Int J Mol Sci 14 2013 9379 9395
100. S. Carloni, S. Perrone, and G. Buonocore Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats J Pineal Res 44 2008 157 164
101. D. Alonso-Alconada, A. Alvarez, J. Lacalle, and E. Hilario Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia Histol Histopathol 27 2012 771 783
102. N.J. Robertson, S. Faulkner, and B. Fleiss Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model Brain 136 2013 90 105
103. V. Biran, A. Phan Duy, and F. Decobert Is melatonin ready to be used in preterm infants as a neuroprotectant? Dev Med Child Neurol 56 2014 717 723
104. N. Ramanantsoa, B. Fleiss, and M. Bouslama Bench to cribside: the path for developing a neuroprotectant Transl stroke Res 4 2013 258 277
105. M. Eisermann, A. Kaminska, B. Berdougo, and M.L. Brunet Melatonin: experience in its use for recording sleep EEG in children and review of the literature Neuropediatrics 41 2010 163 166
106. M.R. Ashrafi, M. Mohammadi, and J. Tafarroji Melatonin versus chloral hydrate for recording sleep EEG Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc 14 2010 235 238
107. E. Wassmer, P.F. Carter, and E. Quinn Melatonin is useful for recording sleep EEGs: a prospective audit of outcome Dev Med Child Neurol 43 2001 735 738
108. J. Sander, M.G. Shamdeen, and S. Gottschling Melatonin does not influence sleep deprivation electroencephalogram recordings in children Eur J Pediatr 171 2012 675 679
109. H. Espezel, C. Graves, and J.E. Jan Melatonin as a sedation substitute for diagnostic procedures Dev Med Child Neurol 42 2000 646 647
110. C.M. Schmidt, J.E. Bohlender, and D. Deuster The use of melatonin as an alternative to sedation in children undergoing brainstem audiometry Laryngo- Rhino- otologie 83 2004 523 528
111. E. Wassmer, M. Fogarty, and A. Page Melatonin as a sedation substitute for diagnostic procedures: MRI and EEG Dev Med Child Neurol 43 2001 136
112. K. Johnson, A. Page, H. Williams, E. Wassemer, and W. Whitehouse The use of melatonin as an alternative to sedation in uncooperative children undergoing an MRI examination Clin Radiol 57 2002 502 506
113. I.M. Andersen, J. Kaczmarska, S.G. McGrew, and B.A. Malow Melatonin for insomnia in children with autism spectrum disorders J Child Neurol 23 2008 482 485
114. M.B. Wasdell, J.E. Jan, and M.M. Bomben A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities J Pineal Res 44 2008 57 64
115. J.E. Nagtegaal, M. Smits, Y.G. Van Der Meer, and M.G. Fischer-Steenvoorden Melatonin: a survey of suspected adverse drug reactions Sleep-Wake Res Netherl 7 1996 115 118
116. I.V. Zhdanova, R.J. Wurtman, and M.M. Regan Melatonin treatment for age-related insomnia J Clin Endocrinol Metab 86 2001 4727 4730
117. V. Srinivasan, W.D. Spence, and S.R. Pandi-Perumal Melatonin and human reproduction: shedding light on the darkness hormone Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 25 2009 779 785
118. A. Carrillo-Vico, R.J. Reiter, and P.J. Lardone The modulatory role of melatonin on immune responsiveness Curr Opin Investig Drugs 7 2006 423 431
119. B. Malow, K.W. Adkins, and S.G. McGrew Melatonin for sleep in children with autism: a controlled trial examining dose, tolerability, and outcomes J Autism Dev Disord 42 2012 1729 1737 author reply 38
120. J.M. Damiani, B.V. Sweet, and P. Sohoni Melatonin: an option for managing sleep disorders in children with autism spectrum disorder Am J Health-Syst Pharm AJHP Off J Am Soc Health-Sys Pharm 71 2014 95 101
121. C.A. Ray Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans J Physiol 551 2003 1043 1048